Equities
  • Price (BRL)251.27
  • Today's Change-0.73 / -0.29%
  • Shares traded600.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Jan 24 2020 19:16 GMT.
More ▼

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
MDT:NYQ since
announced
Transaction
value
Stimgenics LLCDeal completed08 Jan 202008 Jan 2020Deal completed4.17%--
Klue Labs IncDeal completed17 Dec 201917 Dec 2019Deal completed4.12%--
Titan Spine IncDeal completed09 May 201909 May 2019Deal completed34.00%--
Advanced Cardiac Therapeutics IncAnnounced24 Jan 201924 Jan 2019Announced36.83%--
Data delayed at least 15 minutes, as of Jan 24 2020 23:30 GMT.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.